Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), encompasses a range of liver conditions from steatosis to nonalcoholic steatohepatitis (NASH). Its prevalence, especially among patients with metabolic syndrome, highlights i...
Saved in:
Main Authors: | Tatjana Radosavljevic (Author), Milica Brankovic (Author), Janko Samardzic (Author), Jasmina Djuretić (Author), Dusan Vukicevic (Author), Danijela Vucevic (Author), Vladimir Jakovljevic (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging therapies for MASLD and their impact on plasma lipids
by: Madison Nguyen, et al.
Published: (2024) -
Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10
by: Yanying Yang, et al.
Published: (2024) -
Mitochondrial transplantation as a promising therapy for mitochondrial diseases
by: Tian-guang Zhang, et al.
Published: (2023) -
Screening for social determinants of health among populations at risk for MASLD: a scoping review
by: Rebecca G. Kim, et al.
Published: (2024) -
Mitochondrial Alterations in Rett Syndrome
by: J Gordon Millichap
Published: (1989)